Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Reinvestment Rate
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting €184.52 Million (capex €170.49 Million plus investments €-14.03 Million) from operating cash flow of €1.69 Billion. Check 5UM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genertec Universal Medical Group Company Limited Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Genertec Universal Medical Group Company Limited across 4 annual periods. Explore 5UM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year capital reinvestment analysis for Genertec Universal Medical Group Company Limited. For live market cap and broader valuation context, see Genertec Universal Medical Group Company market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €1.01 Billion | €5.78 Billion | €988.91 Million | ▼ -87.9% |
| 2024 | 1.44x | €1.64 Billion | €1.14 Billion | €1.26 Billion | ▲ +267.1% |
| 2023 | 0.39x | €1.96 Billion | €4.99 Billion | €896.83 Million | ▲ +4.0% |
| 2022 | 0.38x | €774.64 Million | €2.06 Billion | €608.09 Million | — |